Viral Diagnostic Test Kits Market - Global Industry Analysis

Viral Diagnostic Test Kits Market Size - By Type (Influenza test kits, Hepatitis test kits, Human immunodeficiency virus test kits, and Respiratory syncytial virus test kits), By Test (Traditional Tests and Rapid Tests), By End-User (Diagnostic & clinical laboratories, Academic & research institutes, and Contract research organizations), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 20-Apr-2021 Category: Medical Device Report Format : PDF Pages: 114 Report Code: ZMR-6127 Status : Published

The global Viral Diagnostic Test Kits market accrued earnings worth approximately 12 (USD Billion) in 2019 and is predicted to gain revenue of about 17(USD Billion) by 2026, is set to record a CAGR of nearly 8.1% over the period from 2020 to 2026.

Description

Viral Diagnostic Test Kits Market Size

The global Viral Diagnostic Test Kits market accrued earnings worth approximately 12 (USD Billion) in 2019 and is predicted to gain revenue of about 17(USD Billion) by 2026, is set to record a CAGR of nearly 8.1% over the period from 2020 to 2026. The report offers an assessment and analysis of the Viral Diagnostic Test Kits market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2017 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion).

Overview

One of the most proficient methods for preventing the spread of SARS-CoV-2 is to create accurate rapid diagnostic tests. Apparently, there are many serological, imaging, and molecular techniques as well as various diagnostic kits for diagnosing infection in clinics. In addition to this, the SARS-CoV-2 determining methods used by labs and firms include molecular methods having the ability to detect viral RNA sequencing, rapid diagnostic tests for identifying virus presence depending on antigens, and imaging methods for determining changes occurring in lungs.

In the molecular approach, PCR and high throughput sequencing are used for identifying virus presence in respiratory samples. Radio imaging methods such as CT-scan are utilized for measuring the level of infection. However, rapid diagnostic tests are used prominently as they are time-savvy and accurate.  They make use of antigens or antibodies for determining virus presence in individuals.

Apart from this, antibody-based testing methods including ELISA are utilized for determining antibodies in samples of patients and assessing whether the subject was infected earlier or not. Furthermore, antibody tests are also done by using blood samples as well as samples of serum and plasma. Furthermore, antigen tests help in detecting the viral antigen presence in respiratory samples along with identifying active infection. Furthermore, viral diagnostic test kits are used for performing these antibody or antigen tests for detecting the virus in the human body. This will steer the viral diagnostic test kits market size.

Global Virtual reality Market

To know more about this report, request a sample copy.

Market Growth Dynamics

With the onset of the COVID pandemic, the market for viral diagnostic test kits is anticipated to gain traction over the upcoming years. Apart from this, swine flu and HIV has further added to the demand for viral diagnostic test kits in recent years, thereby driving business trends. A prominent surge in viral infections including respiratory syncytial virus and hepatitis is projected to steer viral diagnostic test kits market size in the years ahead. In addition to this, an outbreak of new viral strains along with the inception of virus infections including Ebola and hemorrhagic fever will create humungous product demand within the next couple of years. Nonetheless, the huge costs of viral diagnostic test kits can restrict the growth of the viral diagnostic test kits industry over the upcoming years.

Moreover, the launching of new rapid test kits and laws favoring the use of viral diagnostic test kits along with the rapid spread of virus-like COVID-19 among the population will chart a profitable growth map for the viral diagnostic test kits industry within the next couple of years. Apart from this, firms are trying to develop new kits to determine the presence of viruses such as COVID-19. Citing an instance, on 9th April 2021, LUCIRA – a medical tech firm producing new infectious ailment test kits, announced successful detection of double mutant COVID-19 variant through its viral diagnostic test kit referred as LUCIRA molecular diagnostic test kit. In addition to this, earlier in March 2021, U.S.-based firm Cepheid is likely to produce point-of-care COVID-19 diagnostic test kits in the Indian sub-continent. Such strategic moves can lay strong foundations for viral diagnostic test kits market growth across the globe in the coming years.

Regional Landscape

North America To Continue Market Domination In Near Future

The growth of the market in the North American sub-continent over the assessment period is attributed to increasing in cases of COVID in countries such as the U.S.  Apart from this, the production of new test kits along with favorable government policies over the manufacture of the products will create strong growth platform for viral diagnostic test kits industry in the sub-continent over the expected timespan. The presence of giant firms in the region will prop up the business landscape in the next decade, thereby further adding to regional market value.

Report Scope

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

To know more about this report, Request For Customization.

Competitive Landscape

Key participants profiled in the report are Beckman Coulter, Inc., Bundi International Diagnostics Ltd., F. Hoffman La Roche, Ltd., Nectar Lifesciences Ltd., Abbott Laboratories, PerkinElmer, Inc., BioMerieux SA, Autobio Diagnostics Co., Ltd., Siemens Healthineers AG, Luminex Corporation, Becton, Dickinson and Company, Merck & Co., Inc., Bio-Rad Laboratories, Inc., Quidel Corporation, CerTest Biotec, S.L., Qiagen NV, CorisBioconcept SPRL, Hologic Inc., Mylan NV, and Thermo Fisher Scientific, Inc.

The global Viral Diagnostic Test Kits Market is segmented as follows:

By Test  

  • Traditional Tests
  • Rapid Test

By Type

  • Influenza test kits
  • Hepatitis test kits
  • Human immunodeficiency virus test kits
  • Respiratory syncytial virus test kits 

By End-User

  • Diagnostic & clinical laboratories
  • Academic & research institutes
  • Contract research organizations

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Viral Diagnostic Test Kits Market, 2016–2026(USD Billion)
    • 2.2. Viral Diagnostic Test Kits Market: Snapshot
  • Chapter 3. Global Viral Diagnostic Test Kits Market– Industry Analysis
    • 3.1. Viral Diagnostic Test Kits Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Introduction of new rapid test kits and laws favoring use of viral diagnostic test kits along with rapid spread of virus like COVID 19 among the population will chart a profitable growth map for viral diagnostic test kits industry within the next couple of years.
      • 3.2.2. With onset of COVID pandemic, the market for viral diagnostic test kits is anticipated to gain traction over the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Type
      • 3.4.2. Market attractiveness analysis By Test
      • 3.4.3. Market attractiveness analysis By End-User
  • Chapter 4. Global Viral Diagnostic Test Kits Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Viral Diagnostic Test Kits Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Viral Diagnostic Test Kits Market– Type Analysis
    • 5.1. Global Viral Diagnostic Test Kits Marketoverview: By Type
      • 5.1.1. Global Viral Diagnostic Test Kits Marketshare, By Type , 2019 and 2026
    • 5.2. Influenza test kits
      • 5.2.1. Global Telecommunications Products Marketby Influenza test kits , 2016–2026(USD Billion)
    • 5.3. Hepatitis test kits
      • 5.3.1. Global Viral Diagnostic Test Kits Marketby Hepatitis test kits, 2016–2026(USD Billion)
    • 5.4. Human immunodeficiency virus test kits
      • 5.4.1. Global Viral Diagnostic Test Kits Market by Human immunodeficiency virus test kits, 2016–2026(USD Billion)
    • 5.5. Respiratory syncytial virus test kits
      • 5.5.1. Global Viral Diagnostic Test Kits Market by Respiratory syncytial virus test kits, 2016–2026(USD Billion)
  • Chapter 6. Global Viral Diagnostic Test Kits Market– Test Analysis
    • 6.1. Global Viral Diagnostic Test Kits Market overview: By Test
      • 6.1.1. Global Viral Diagnostic Test Kits Market share, By Test , 2019 and 2026
    • 6.2. Traditional Tests
      • 6.2.1. Global Telecommunications Products Marketby Traditional Tests , 2016–2026(USD Billion)
    • 6.3. Rapid Tests
      • 6.3.1. Global Viral Diagnostic Test Kits Marketby Rapid Tests, 2016–2026(USD Billion)
  • Chapter 7. Global Viral Diagnostic Test Kits Market– End-User Analysis
    • 7.1. Global Viral Diagnostic Test Kits Market overview: By End-User
      • 7.1.1. Global Viral Diagnostic Test Kits Marketshare, By End-User , 2019 and 2026
    • 7.2. Diagnostic & clinical laboratories
      • 7.2.1. Global Telecommunications Products Market by Diagnostic & clinical laboratories, 2016–2026(USD Billion)
    • 7.3. Academic & research institutes
      • 7.3.1. Global Viral Diagnostic Test Kits Market by Academic & research institutes, 2016–2026(USD Billion)
    • 7.4. Contract research organizations
      • 7.4.1. Global Viral Diagnostic Test Kits Market by Contract research organizations, 2016–2026(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Beckman Coulter, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Bundi International Diagnostics Ltd.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. F. Hoffman La Roche, Ltd.
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfolio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. Nectar Lifesciences Ltd.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfolio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. Abbott Laboratories
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfolio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. PerkinElmer, Inc.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfolio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. BioMerieux SA
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfolio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Autobio Diagnostics Co., Ltd.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfolio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Siemens Healthineers AG
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfolio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. Luminex Corporation
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfolio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. Becton, Dickinson and Company
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfolio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development
    • 8.12. Merck & Co., Inc.
      • 8.12.1. Overview
      • 8.12.2. Financials
      • 8.12.3. Product Portfolio
      • 8.12.4. Business Strategy
      • 8.12.5. Recent Development
    • 8.13. Bio-Rad Laboratories, Inc.
      • 8.13.1. Overview
      • 8.13.2. Financials
      • 8.13.3. Product Portfolio
      • 8.13.4. Business Strategy
      • 8.13.5. Recent Development
    • 8.14. Quidel Corporation
      • 8.14.1. Overview
      • 8.14.2. Financials
      • 8.14.3. Product Portfolio
      • 8.14.4. Business Strategy
      • 8.14.5. Recent Development
    • 8.15. CerTest Biotec , S.L.
      • 8.15.1. Overview
      • 8.15.2. Financials
      • 8.15.3. Product Portfolio
      • 8.15.4. Business Strategy
      • 8.15.5. Recent Development
    • 8.16. Qiagen NV
      • 8.16.1. Overview
      • 8.16.2. Financials
      • 8.16.3. Product Portfolio
      • 8.16.4. Business Strategy
      • 8.16.5. Recent Development
    • 8.17. CorisBioconcept SPRL
      • 8.17.1. Overview
      • 8.17.2. Financials
      • 8.17.3. Product Portfolio
      • 8.17.4. Business Strategy
      • 8.17.5. Recent Development
    • 8.18. Hulogic Inc.
      • 8.18.1. Overview
      • 8.18.2. Financials
      • 8.18.3. Product Portfolio
      • 8.18.4. Business Strategy
      • 8.18.5. Recent Development
    • 8.19. Thermo Fisher Scientific, Inc.
      • 8.19.1. Overview
      • 8.19.2. Financials
      • 8.19.3. Product Portfolio
      • 8.19.4. Business Strategy
      • 8.19.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Viral Diagnostic Test Kits Market, 2016–2026(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Viral Diagnostic Test Kits Market Attractiveness, By Type   
6. Global Viral Diagnostic Test Kits Market Attractiveness, By Test  
7. Global Viral Diagnostic Test Kits Market Attractiveness, By End-User  
8. Global Viral Diagnostic Test Kits Market share by Type,2019 and 2026 (USD Billion)
9. Global Viral Diagnostic Test Kits Market by Influenza test kits,2016–2026(USD Billion)
10. Global Viral Diagnostic Test Kits Market by Hepatitis test kits,2016–2026(USD Billion)
11. Global Viral Diagnostic Test Kits Market by Human immunodeficiency virus test kits,2016–2026(USD Billion)
12. Global Viral Diagnostic Test Kits Market by Respiratory syncytial virus test kits,2016–2026(USD Billion)
13. Global Viral Diagnostic Test Kits Marketshare by Test,2019 and 2026 (USD Billion)
14. Global Viral Diagnostic Test Kits Market by Rapid Tests, 2016–2026(USD Billion)
15. Global Viral Diagnostic Test Kits Market by Traditional Tests , 2016–2026(USD Billion)
16. Global Viral Diagnostic Test Kits Market share by End-User,2019 and 2026 (USD Billion)
17. Global Viral Diagnostic Test Kits Market by Diagnostic & clinical laboratories, 2016–2026(USD Billion)
18. Global Viral Diagnostic Test Kits Market by Academic & research institutes, 2016–2026(USD Billion)
19. Global Viral Diagnostic Test Kits Market by Contract research organizations, 2016–2026(USD Billion)
20. Global Viral Diagnostic Test Kits Market by Industrial, 2016–2026(USD Billion)
21. Global Viral Diagnostic Test Kits Market share, by Region, 2019 and 2026
22. North America Viral Diagnostic Test Kits Market, 2016–2026(USD Billion)
23. Europe Viral Diagnostic Test Kits Market, 2016–2026(USD Billion)
24. Asia Pacific Viral Diagnostic Test Kits Market, 2016–2026(USD Billion)
25. Latin America Viral Diagnostic Test Kits Market, 2016–2026(USD Billion)
26. The Middle East and Africa Viral Diagnostic Test Kits Market, 2016–2026(USD Billion)


Table Of Tables

List of Tables

1. Global Viral Diagnostic Test Kits Market: snapshot
2. Drivers of the Viral Diagnostic Test Kits Market: impact analysis
3. North America Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
4. North America Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
5. North America Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
6. The U.S. Viral Diagnostic Test Kits Market Revenue, By Type, 2016–2026(USD Billion)
7. The U.S. Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
8. The U.S. Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
9. Rest of North America Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
10. Rest of North America Viral Diagnostic Test Kits Market revenue, By Test  ,2016–2026(USD Billion)
11. Rest of North America Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
12. Europe Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
13. Europe Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
14. Europe Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
15. UK Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
16. UK Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
17. UK Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
18. France Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
19. France Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
20. France Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
21. Germany Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
22. Germany Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
23. Germany Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
24. Rest of Europe Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
25. Rest of Europe Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
26. Rest of Europe Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
27. Asia Pacific Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
28. Asia Pacific Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
29. Asia Pacific Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
30. China Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
31. China Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
32. China Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
33. Japan Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
34. Japan Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
35. Japan Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
36. India Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
37. India Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
38. India Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
39. Rest of Asia Pacific Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
40. Rest of Asia Pacific Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
41. Rest of Asia Pacific Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
42. Latin America Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
43. Latin America Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
44. Latin America Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
45. Brazil Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
46. Brazil Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
47. Brazil Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
48. Rest of Latin America Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
49. Rest of Latin America Viral Diagnostic Test Kits Market revenue, By Test  , 2016–2026(USD Billion)
50. Rest of Latin America Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
51. The Middle East and Africa Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
52. The Middle East and Africa Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
53. The Middle East and Africa Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)
54. Saudi Arabia Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
55. Saudi Arabia Viral Diagnostic Test Kits Market Revenue, By Test,2016–2026(USD Billion)
56. Saudi Arabia Viral Diagnostic Test Kits Market Revenue, By End-User,2016–2026(USD Billion)
57. South Africa Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
58. South Africa Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
59. South Africa Viral Diagnostic Test Kits Market Revenue, By End-User,2016–2026(USD Billion)
60. Rest of the Middle East & Africa Viral Diagnostic Test Kits Market revenue, By Type, 2016–2026(USD Billion)
61. Rest of the Middle East & Africa Viral Diagnostic Test Kits Market revenue, By Test,2016–2026(USD Billion)
62. Rest of the Middle East & Africa Viral Diagnostic Test Kits Market revenue, By End-User,2016–2026(USD Billion)

Methodology

Choose License Type

FrequentlyAsked Questions

With onset of COVID pandemic, the market for viral diagnostic test kits is anticipated to gain traction over the upcoming years. Apart from this, swine flu and HIV has further added to the demand for viral diagnostic test kits in the recent years, thereby driving business trends. A prominent surge in the viral infections including respiratory syncytial virus and hepatitis is projected to steer viral diagnostic test kits market size in the years ahead. In addition to this, outbreak of new viral strains along with inception of virus infections including Ebola and hemorrhagic fever will create humungous product demand within the next couple of years.

According to Zion market research report, the global Viral Diagnostic Test Kits market accrued earnings worth approximately 12 (USD Billion) in 2019 and is predicted to gain revenue of about 17(USD Billion) by 2026, is set to record a CAGR of nearly 8.1% over the period from 2020 to 2026.

North American region will contribute lucratively towards the global market value over the estimated timeline. The swift expansion of telecommunication Products industry in the North America over the forecast timeline can be ascribed to increase in cases of COVID in countries such as the U.S.  Apart from this, production of new test kits along with favorable government policies over the manufacture of the products will create strong growth platform for viral diagnostic test kits industry in the sub-continent over the expected timespan. Presence of giant firms in the region will prop up business landscape in the next decade, thereby further adding to regional market value.

The key market participants include Beckman Coulter, Inc., Bundi International Diagnostics Ltd., F. Hoffman La Roche, Ltd., Nectar Lifesciences Ltd., Abbott Laboratories, PerkinElmer, Inc., BioMerieux SA, Autobio Diagnostics Co., Ltd., Siemens Healthineers AG, Luminex Corporation, Becton, Dickinson and Company, Merck & Co., Inc., Bio-Rad Laboratories, Inc., Quidel Corporation, CerTest Biotec, S.L., Qiagen NV, CorisBioconcept SPRL, Hologic Inc., Mylan NV, and Thermo Fisher Scientific, Inc.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed